FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers
Adding Herceptin to chemotherapy in gastric cancer patients with ERBB2-positive tumors produced an 85% response rate.
	For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org


Powering progress to defeat stomach cancer.


Powering progress to defeat stomach cancer.
MORE INFODONATEDONATEMORE INFO